RT Journal Article
SR Electronic
T1 Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.23.20099671
DO 10.1101/2020.05.23.20099671
A1 Cercy, Steven P.
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.23.20099671.abstract
AB Several medical risk factors for COVID-19 have been identified. However, additional factors likely account for some of the observed variability in COVID-19 outcomes. We examined the relationships between chronic psychiatric disorders and COVID-19 morbidity and mortality. Medical records from a cohort of 141 skilled nursing facility residents were reviewed. Multivariate logistic regression modeling determined psychiatric predictors for hospital admission, intensive care unit (ICU) admission, and mortality after controlling for medical risk factors. After controlling for all medical risk, altered mental status (AMS) was a predictor of hospital admission (p = .005), ICU admission (p = .015), and mortality (p = .006). Anxiety (p = .008) and dementia (p = .040) were also associated with an elevated risk of death. A simplified model yielded comparable findings. AMS was associated with a greater risk of hospital admission (p = .002), ICU admission (p = .024), and mortality (p = .006); anxiety (p = .002) was also a powerful predictor of mortality.After accounting for medical risk, morbidity and mortality due to COVID-19 are higher than expected in patients with chronic anxiety disorders, dementia, and AMS. Mechanisms underlying adverse outcomes remain to be determined. Links to neuroendocrine modulation, inflammation, and immune functioning are considered. Furthermore, outcomes in patients with dementia and AMS suggest COVID-19 poses substantial risk to the brain.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementThis study was not funded.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval for rapid communications involving studies of veterans with COVID-19 was waived by the Institutional Review Board of the VA New York Harbor Healthcare System.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request.